Diabetic ketoacidosis risk during the COVID-19 pandemic
Errataetall: |
CommentOn: Lancet Diabetes Endocrinol. 2021 Oct;9(10):671-680. - PMID 34481558 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
The lancet. Diabetes & endocrinology - 9(2021), 10 vom: 12. Okt., Seite 643-644 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vellanki, Priyathama [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 23.09.2021 Date Revised 23.09.2021 published: Print-Electronic CommentOn: Lancet Diabetes Endocrinol. 2021 Oct;9(10):671-680. - PMID 34481558 Citation Status MEDLINE |
---|
doi: |
10.1016/S2213-8587(21)00241-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330239775 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330239775 | ||
003 | DE-627 | ||
005 | 20231225210846.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S2213-8587(21)00241-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1100.xml |
035 | |a (DE-627)NLM330239775 | ||
035 | |a (NLM)34481553 | ||
035 | |a (PII)S2213-8587(21)00241-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vellanki, Priyathama |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diabetic ketoacidosis risk during the COVID-19 pandemic |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.09.2021 | ||
500 | |a Date Revised 23.09.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: Lancet Diabetes Endocrinol. 2021 Oct;9(10):671-680. - PMID 34481558 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Comment | |
700 | 1 | |a Umpierrez, Guillermo E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The lancet. Diabetes & endocrinology |d 2013 |g 9(2021), 10 vom: 12. Okt., Seite 643-644 |w (DE-627)NLM233773398 |x 2213-8595 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2021 |g number:10 |g day:12 |g month:10 |g pages:643-644 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2213-8587(21)00241-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2021 |e 10 |b 12 |c 10 |h 643-644 |